Affordable Access

Access to the full text

The impact of familial Mediterranean fever on reproductive system

Authors
  • Yanmaz, Muyesser Nergiz1
  • Özcan, Ayşet Jane2
  • Savan, Kadir2
  • 1 Internal Medicine and Rheumatology, Medicalpark Hospital, Istanbul Kemerburgaz University School of Medicine, Kültür sok No. 1, Istanbul, 34160, Turkey , Istanbul (Turkey)
  • 2 Obstetrics and Gynecology, Medicalpark Hospital, Istanbul Kemerburgaz University School of Medicine, Kültür sok No. 1, Istanbul, 34160, Turkey , Istanbul (Turkey)
Type
Published Article
Journal
Clinical Rheumatology
Publisher
Springer-Verlag
Publication Date
Jun 14, 2014
Volume
33
Issue
10
Pages
1385–1388
Identifiers
DOI: 10.1007/s10067-014-2709-9
Source
Springer Nature
Keywords
License
Yellow

Abstract

Familial Mediterranean fever (FMF) is an autosomal recessive disease characterized by recurrent attacks of fever, peritonitis, pleuritis, arthritis, or erysipelas-like skin lesion. FMF is the most common periodic febrile syndrome affecting more than 150,000 people worldwide. The majority of patients develop FMF before the age of 20. FMF may cause amyloidosis, which mainly affects the kidneys but may also be accumulated in other organs such as the heart, gastrointestinal tract, and reproductive organs. FMF being a systemic disorder with a risk for amyloidosis, affecting patients in their childbearing years, and with its lifelong colchicine therapy raises concern about its effect on the reproductive system. In this article, we review the impact of FMF and its treatment to the reproductive system of male and female patients, pregnancy, and lactation.

Report this publication

Statistics

Seen <100 times